Sci Pharmtech Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8
Ending by 2030
Oct 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 28, 2027The maintenance fee for Method for purification of terpenoid amino alcohol derivatives (US 11,739,050) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,420,832 | Optically active methylhydroxylaminopropanol derivative and its use as intermediate for preparation of (S)-(-)-3-methylamino-1-(-2-thienyl)propan-1-ol In force · From the USPTO record | In force | From the USPTO record | |
| US 7,829,731 | Methylhydroxylaminopropanol derivative and its use as intermediate for preparation of 3-methylamino-1-(2-thienyl)propan-1-OL In force · From the USPTO record | In force | From the USPTO record | |
| US 8,168,805 | Optically active methylhydroxylaminopropanol compound and its use as intermediate for preparation of (S)-(−)-3-methylamino-1-(2-thienyl)propan-1-ol In force · From the USPTO record | In force | From the USPTO record | |
| US 8,148,549 | Preparation of (S)-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl) propylamine using optically active methylhydroxylaminopropanol compound as an intermediate In force · From the USPTO record | In force | From the USPTO record | |
| US 8,957,227 | Preparation of Duloxetine Hydrochloride Using Optically Active Methylhydroxylaminopropanol Compound as an Intermediate In force · Medium confidence | In force | Medium confidence | |
| US 8,729,300 | Method for preparing metal salt of valproic acid In force · From the USPTO record | In force | From the USPTO record | |
| US 8,614,336 | Process for preparing N-methyl-N-hydroxyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine derivative In force · From the USPTO record | In force | From the USPTO record | |
| US 8,299,305 | Method for preparing atomoxetine In force · From the USPTO record | In force | From the USPTO record | |
| US 8,273,917 | Method for preparing chiral baclofen In force · From the USPTO record | In force | From the USPTO record | |
| US 8,530,674 | Process for preparing (S)-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine by using optically active methylhydroxylaminopropanol compound as intermediate In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 13: 2 patents in force now held by others · 2 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 no status recorded